Susceptibilidad antimicrobiana de Campylobacter jejuni aislado de coprocultivos en Santiago de Chile / Antimicrobial susceptibility of Campylobacter jejuni isolates from stool cultures in Santiago, Chile
Rev. chil. infectol
;
26(6): 511-514, dic. 2009. tab
Article
in Spanish
| LILACS
| ID: lil-536830
ABSTRACT
Campylobacter jejuni is a common agent of enterocolitis in humans. Campy lobacteriosis has been recognized as a zoonotic disease whose reservoir is the intestinal flora of poultry. The reposition of fluid and electrolytes is the recommended treatment, and antimicrobials are required only in severe and/or in prolonged disease. Given the emergence of resistance to drugs commonly used in the treatment of acute diarrhea, we studied the antimicrobial susceptibility of 73 strains oí Campylobacter jejuni isolated from stool culture. The antimicrobials tested were erythromycin, azithromycin, ampicillin and ciprofloxacin. Of the 73 strains tested by E-test, 32.4 percent were resistant to ciprofloxacin and 6.4 percent were resistant to ampicillin. Resistance to erythromycin and azithromycin was not detected. The surveillance of antimicrobial resistance of Campylobacter jejuni is important in the evaluation of empirically used antimicrobials in the treatment of bacterial enterocolitis.
Full text:
Available
Index:
LILACS (Americas)
Main subject:
Campylobacter jejuni
/
Feces
/
Anti-Bacterial Agents
Type of study:
Observational study
Limits:
Adolescent
/
Adult
/
Aged
/
Child
/
Humans
Country/Region as subject:
South America
/
Chile
Language:
Spanish
Journal:
Rev. chil. infectol
Journal subject:
Communicable Diseases
Year:
2009
Type:
Article
Affiliation country:
Chile
Institution/Affiliation country:
Pontificia Universidad Católica de Chile/CL
/
Universidad Austral de Chile/CL
Similar
MEDLINE
...
LILACS
LIS